CN103739667B - 卵巢癌特异的肿瘤抗原肽及其制备方法 - Google Patents
卵巢癌特异的肿瘤抗原肽及其制备方法 Download PDFInfo
- Publication number
- CN103739667B CN103739667B CN201310439063.2A CN201310439063A CN103739667B CN 103739667 B CN103739667 B CN 103739667B CN 201310439063 A CN201310439063 A CN 201310439063A CN 103739667 B CN103739667 B CN 103739667B
- Authority
- CN
- China
- Prior art keywords
- cell
- peptide
- magnetic bead
- oophoroma
- culture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310439063.2A CN103739667B (zh) | 2013-09-24 | 2013-09-24 | 卵巢癌特异的肿瘤抗原肽及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310439063.2A CN103739667B (zh) | 2013-09-24 | 2013-09-24 | 卵巢癌特异的肿瘤抗原肽及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103739667A CN103739667A (zh) | 2014-04-23 |
CN103739667B true CN103739667B (zh) | 2017-08-25 |
Family
ID=50496751
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310439063.2A Active CN103739667B (zh) | 2013-09-24 | 2013-09-24 | 卵巢癌特异的肿瘤抗原肽及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103739667B (zh) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB201501017D0 (en) * | 2014-12-23 | 2015-03-04 | Immatics Biotechnologies Gmbh | Novel peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers |
DK3236985T4 (da) | 2014-12-23 | 2022-11-28 | Immatics Biotechnologies Gmbh | Hidtil ukendte peptider og kombination af peptider til anvendelse ved immunterapi mod hepatocellulært karcinom (hcc) og andre cancere |
CN106589066B (zh) * | 2016-11-03 | 2020-06-23 | 陕西师范大学 | 人卵巢癌细胞特异性结合的多肽及其应用 |
US11814432B2 (en) * | 2017-09-20 | 2023-11-14 | The University Of British Columbia | Anti-HLA-A2 antibodies, related chimeric antigen receptors, and uses thereof |
JP7023942B2 (ja) * | 2017-09-20 | 2022-03-03 | 豊宥科技股▲フン▼有限公司 | 卵巣癌バイオマーカーおよびその使用 |
CN110790815B (zh) * | 2019-11-29 | 2021-06-25 | 中国人民解放军陆军军医大学第一附属医院 | 一种从妇科肿瘤组织中提取天然提呈抗原肽的方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1356048A2 (en) * | 2000-12-04 | 2003-10-29 | Argonex Pharmaceuticals | Cytotoxic t-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer |
US6867283B2 (en) * | 2001-05-16 | 2005-03-15 | Technion Research & Development Foundation Ltd. | Peptides capable of binding to MHC molecules, cells presenting such peptides, and pharmaceutical compositions comprising such peptides and/or cells |
-
2013
- 2013-09-24 CN CN201310439063.2A patent/CN103739667B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN103739667A (zh) | 2014-04-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103739667B (zh) | 卵巢癌特异的肿瘤抗原肽及其制备方法 | |
US20240122976A1 (en) | Immune cells expressing an antigen binding receptor and a chimeric costimulatory receptor | |
JP2022173331A (ja) | 寛容を誘導するために正常b細胞を枯渇させるためのcart19の使用 | |
RU2615460C2 (ru) | Иммуногенные пептиды для применения в профилактике и/или лечении инфекционных заболеваний, аутоиммунных заболеваний, иммунных ответов на аллогенные факторы, аллергических заболеваний, опухолей, отторжения трансплантата и иммунных ответов против вирусных векторов. используемых для генной терапии или генной вакцинации | |
JP2020124214A (ja) | 自己癌抗原特異的cd8+t細胞の分離及び増殖方法 | |
TW201619378A (zh) | 以car為基礎之免疫治療 | |
CA2479288C (en) | Process for producing cytotoxic lymphocyte | |
US8323655B2 (en) | Identification of antigenic peptides from multiple myeloma cells | |
EP3259284B1 (en) | A fully-human t cell receptor specific for the 369-377 epitope derived from the her2/neu (erbb2) receptor protein | |
EP2328923A2 (en) | Cd133 epitopes | |
EP4110799A1 (en) | Methods for ex vivo enrichment and expansion of tumor reactive t cells and related compositions thereof | |
JP2017081836A (ja) | 細胞傷害性t細胞の作製方法 | |
US20200308279A1 (en) | Chimeric antigen receptors | |
Ding et al. | The performance and perspectives of dendritic cell vaccines modified by immune checkpoint inhibitors or stimulants | |
JP4365405B2 (ja) | Mhc分子と結合する腫瘍関連ペプチド | |
Panelli et al. | Overview of melanoma vaccines and promising approaches | |
KR20210141599A (ko) | Cd28 t 세포의 배양액, 조성물 및 그 사용 방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20200117 Address after: Room 901, east side, 9 / F, building G25, building 0005, east side of Tailu road and north side of Xinyang Road, Taizhou City, Jiangsu Province Patentee after: Jiangsu Xidier Biological Technology Co. Ltd. Address before: 200233 room 11, building 103, No. 08, Xuhui District, Shanghai, Caobao Road Patentee before: SHANGHAI YUYAN BIOTECHNOLOGY CO., LTD. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20200908 Address after: 200333, room 4, building 879, Lane 401, Zhongjiang Road, Shanghai, Putuo District Patentee after: SHANGHAI YUYAN BIOTECH Co.,Ltd. Address before: Room 901, east side, 9 / F, building G25, building 0005, east side of Tailu road and north side of Xinyang Road, Taizhou City, Jiangsu Province Patentee before: JIANGSU XIDIER BIOTECHNOLOGY Co.,Ltd. |